FDA Approved: BOSAYA — Original Application (Biocon Biologics Inc.)

View source ↗

Summary

FDA approved BOSAYA (denosumab-kyqq) from Biocon Biologics Inc. under an Original Application as a biosimilar to denosumab products, with the same indications a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Hypercalcemia of Malignancy
• Osteoporosis

Drugs mentioned

• BOSAYA (denosumab-kyqq)

Snippet

ORIG AP for BOSAYA (DENOSUMAB-KYQQ)